COSMOS Pharmaceutical (TSE:3349) YoY EBITDA Growth : 16.87% (As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. COSMOS Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was 16.87%.

COSMOS Pharmaceutical's EBITDA per Share for the three months ended in Feb. 2024 was 円220.72.

COSMOS Pharmaceutical YoY EBITDA Growth Historical Data

The historical data trend for COSMOS Pharmaceutical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical YoY EBITDA Growth Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

YoY EBITDA Growth

Get a 7-Day Free Trial

8.17

9.61

19.09

-8.07

4.11

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
YoY EBITDA Growth	Get a 7-Day Free Trial															-3.79	-1.21	0.63	5.50	16.87

COSMOS Pharmaceutical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

COSMOS Pharmaceutical's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

	YoY EBITDA Growth (A: May. 2023 )
=	(EBITDA per Share (A: May. 2023 )	-	EBITDA per Share (A: May. 2022 ))	/	\| EBITDA per Share (A: May. 2022 ) \|
=	(1267.507	-	1217.455)	/	\| 1217.455 \|
=	4.11 %

COSMOS Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2024 )
=	(EBITDA per Share (Q: Feb. 2024 )	-	EBITDA per Share (Q: Feb. 2023 ))	/	\| EBITDA per Share (Q: Feb. 2023 )) \|
=	(220.722	-	188.868)	/	\| 188.868 \|
=	16.87 %

COSMOS Pharmaceutical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines